TribLIVE

| Home


Weather Forecast
 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

AGH heart specialists to join clinical trial

Daily Photo Galleries

Wednesday, March 14, 2012
 

Heart specialists at Allegheny General Hospital announced today that they will join a clinical trial investigating an implantable device designed to provide patients with coronary artery disease an early warning of an impending heart attack.

AGH is the only Pittsburgh area hospital testing the new device — the AngelMed Guardian System.

"Patient outcomes following heart attack are largely dependent upon how quickly the cardiac injury is diagnosed and therapeutic efforts are initiated to restore blood flow to the heart. Delays in that process can result in permanent damage to heart muscle," said Dr. David Lasorda, director of the hospital's division of Interventional cardiology and its principal investigator in the study.

The American Heart Association estimates that one of every five deaths in the United States is attributable to coronary heart disease. Furthermore, 50 percent of heart-attack fatalities occur within one hour of symptom onset and often before the patient even reaches the hospital.

 

 
 


Show commenting policy

Most-Read Stories

  1. Home price gains slow for 6th-straight month
  2. Xxxday’s scouting report: Pirates at Giants
  3. Starkey: Would one big move kill Pirates’ future?
  4. Liriano, Pirates beat Giants, inch closer to lead in NL Central
  5. Guido: Sujansky heads Plum Hall of Fame class of ’14
  6. Steelers offensive linemen looking to build on strong 2013 finish
  7. Pirates inquire about Red Sox LHP Lester
  8. Tech giants lead rush for profits in foreign countries
  9. Review: Pittsburgh CLO crowds should love this gem of a ‘Spam’ a lot
  10. Groups stand against ‘sub-minimum’ wage for workers with disabilities
  11. Dying trees removed from Ford City park
Subscribe today! Click here for our subscription offers.